Johne\u27s Disease, mycoplasma and BVD in Utah - bulk tank milk testing and comparison to previous regional prevalence and individual herd results over time by Wilson, David J. et al.
Volume 5 • Issue 3 • 1000182J Veterinar Sci TechnoloISSN: 2157-7579 JVST, an open access journal 
Open AccessResearch Article
Veterinary
Science & Technology 
Wilson et al., J Veterinar Sci Technolo 2014, 5:3
http://dx.doi.org/10.4172/2157-7579.1000182
Keywords: Johne’s disease; mycoplasma; BVD; Milk; Dairy cattle
Introduction
Johne’s disease (JD, paratuberculosis) is a chronic and important 
digestive tract disease of dairy cattle. Affected animals may exhibit 
no clinical signs, or signs including intermittent or chronic diarrhea, 
decreased milk production, weight loss, emaciation, and death. 
Increased risk of culling accompanies JD infection [1-6]. The etiologic 
agent is Mycobacterium avium subsp. paratuberculosis (MAP) [2].
Johne’s disease is costly, but estimates of financial loss vary 
considerably from $250 million to $1.5 billion annually in the US, and 
may be underestimated [4,6]. Financial loss from JD has been estimated 
from $83 to $380 per infected cow depending on parity/age, $77 in 
increased culling losses per cow for all cows within a herd, and $49 to 
$200 per cow for all cows within infected herds [5,7-9].
Estimates of the proportion of dairy herds infected with JD continue 
to vary between studies, regions, and countries, and it is acknowledged 
that definitive data is lacking. However, herd-level prevalence of JD is 
generally agreed to be increasing in North America, from approximately 
10% to 30% of herds positive 25 years ago [10-12] to 38% to 74% of 
herds more recently, with most regional estimates at approximately 43% 
of dairy herds with JD [13-15].
Mycoplasma spp. are important bacterial pathogens for all ages 
of cattle, and can cause septicemia, pneumonia, arthritis, and death. 
Adult cows may also contract metritis, mastitis, or agalactia. The 
most common mycoplasma affecting cattle is M. bovis; infections 
can also be caused by M. californicum, M. arginini, M. canadense, M. 
bovigenitalium, and other Mycoplasma spp. [16-18]. Because standard 
bacterial culture methods do not isolate Mycoplasma spp., specialized 
laboratory methods are required for diagnosis [18-20].
Mycoplasma is a costly disease per case, but there are few published 
cost estimates. From mastitis and related sequelae alone, losses are 
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Abstract
Dairy herd-level prevalence of Mycobacterium avium subsp. paratuberculosis (MAP), causative agent of Johne’s 
disease (JD), Mycoplasma spp., and Bovine Viral Diarrhea (BVD) virus were estimated in Utah and surrounding 
states and compared to previous surveillance results. Milk was collected at 3-4 day intervals on 5 dates (duplicate 
samples) from each bulk tank on participating farms, samples analyzed separately. One frozen sample was shipped 
to a laboratory for JD/MAP testing with ELISA and real-time PCR, the other paired sample was shipped to another 
laboratory for mycoplasma and BVD testing. Mycoplasma was cultured on modified Hayflick medium, standard 
methods; BVD testing was real-time, RT-PCR. 151/209 (72%) eligible dairy farms participated. Farms detected 
positive (some had multiple diseases) were: 58 JD (38%); 4 mycoplasma (3%); 14 BVD (9%). Sensitivity of testing 
was: 284/528 milks = 54% for JD, 17/61 = 28% for mycoplasma (lower than previous reports), 41/117 = 35% for BVD. 
Of 67 herds positive for JD in 2009, 28 (42%) remained positive, 14 (21%) became test-negative, and 25 (37%) were 
lost to follow up. Of 16 herds positive for mycoplasma in 2007, one (6%) remained positive, 8 (50%) became test-
negative, and 7 (44%) were lost to follow up. Bulk milk remains a practical way to screen dairy herds for presence of 
JD, mycoplasma and BVD, provided that repeated sampling is used. Mycoplasma-positive herds were more likely to 
become test-negative in bulk milk in subsequent years than were JD-positive herds. Prevalence of BVD was similar 
to but slightly lower than previously reported. 
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estimated at $450 per case, and mycoplasma is considered one of the 
most expensive dairy cattle diseases per affected animal [20,21].
Herd-level prevalence of mycoplasma has primarily been estimated 
by bulk tank milk sampling. Prevalence estimates have varied by 
regions in the U.S., from 2% in the Midwest to 9% of dairy herds in the 
West [22]. A recent survey in Québec detected 3% of dairy herds with 
Mycoplasma spp. [23].
Bovine viral diarrhea (BVD) virus has been identified as 
economically important to livestock producers [9,24-27]. In a 
comprehensive review of the economic impact from BVD on dairy 
farms, it was estimated that BVD losses ranged between $10 and $40 
dollars per calving in Denmark [27]. When direct production costs 
were examined in the Canadian dairy system (including milk loss, 
premature voluntary culling and reduced slaughter value, mortality 
loss, and abortion and reproductive loss), total annual costs were $2421 
in an infected herd of 50 cows [9].
The virus infects cattle through transient, usually self-eliminating, 
episodes of viral transmission within the herd or through animals 
persistently infected (PI) during gestation. If the virus infects the fetus 
in utero during the first few months of pregnancy while fetal immunity 
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is being developed, the virus is recognized as “self ” and not eliminated 
nor does it elicit an immune response from the fetus which is therefore 
born PI. A PI animal sheds large amounts of virus and represents the 
most likely reason BVD circulates within herds [28].
BVD has been reported worldwide [29]. The prevalence for PI 
animals on U.S. dairy operations has been reported at 0.13% of cows, 
with 15% of herds having at least one PI animal [30]. Only a few studies 
have used PCR bulk milk sampling to determine herd prevalence of PI 
animals (percentage of herds with at least one PI), ranging from 15% in 
the U.S. [30] to 39% in Denmark [31].
Previous statewide surveillance projects in Utah detected JD in 
39% and Mycoplasma spp. in 7% of Utah dairy herds in 2009 and 2007, 
respectively [32,33]. Objectives of the study reported here included 
estimation of the dairy herd-level prevalence of JD, Mycoplasma spp., 
and BVD virus in Utah and the nearby Intermountain West using a 
repeated sampling scheme. Because JD and mycoplasma were previously 
surveyed in the same Utah dairy region, their herd-level prevalence and 
farm-specific test status were compared to the previous results.
Materials and Methods
Written permission of dairy producers was required in order to 
sample bulk tank milk for testing for JD, Mycoplasma spp., and BVD. 
Information and permission forms were distributed by email, surface 
mail and farm visits by milk buyer field personnel to dairy producers 
in Utah and some producers from surrounding states that sold milk to 
either of the 2 major milk buying companies in Utah.
Collection and handling of bulk tank milk samples
Milk was collected at 3-4 day intervals for a total of 5 sampling dates 
(duplicate samples each date from each bulk tank) on participating 
farms over approximately 15 days. Milk in the tank was agitated for 
at least 5 min before milk haulers collected 2 extra samples into sterile 
vials at the same time they collected their routine testing samples. All 
samples collected by the 2 milk buying companies were frozen at -20° 
C and remained frozen until analysis. Using portable -20°C freezers, all 
samples were transported to the Utah Veterinary Diagnostic Laboratory 
from the collection locations and shipped frozen overnight by courier. 
One sample was sent to Antel BioSystems in Lansing, MI, and the other 
sample collected on the same day was sent to The Dairy Authority 
laboratory in Greeley, CO for testing.
Testing for MAP in bulk tank milk samples
At Antel BioSystems, 2 separate analyses were performed on each 
bulk tank sample as previously described [32,34]. Briefly, each bulk 
tank sample was analyzed for MAP-specific IgG antibody by ELISA and 
for presence of MAP organism by real-time PCR. For ELISA, 100 µL 
of whole milk sample was tested using a commercially available, pre-
absorbed, antibody-capture ELISA (IDEXX Laboratories, Westbrook, 
ME, USA). The assay was performed as specified by the manufacturer 
with the following exceptions: A 1:1.5 dilution of milk sample into 
sample diluent instead of 1:2, 1 h incubation times for sample and 
conjugate steps instead of 0.5 h, 1:67 dilution of concentrated conjugate 
instead of 1:100, and 20 min for color development instead of 10 
min prior to stopping the reaction with 0.5 M sulfuric acid. Positive 
and negative controls supplied with the ELISA kit yielded optical 
density (OD) values (420 nm) between 2.3 and 3.0, and less than 0.10, 
respectively. Scores for ELISA were calculated by subtracting negative 
control values from each sample value and compared to a statistically 
optimized cut-off of 0.1 [34,35]. The cut-off of 0.1 OD, where ELISA 
scores above 0.1 are considered positive for JD, yields a test sensitivity 
and specificity of 52% and 94%, respectively, when compared to 
environmental fecal analysis as the “gold standard” for MAP infection 
in dairy herds [34,35].
For real-time PCR analysis for presence of MAP in milk, 100 uL of 
Tween-20 was added to 50 mL of bulk milk processed by centrifugation 
(2500 x g) and total DNA extracted from the pellet using a DNeasyTM 
spin kit (Qiagen Corporation, Valencia, CA, USA). Real-time PCR 
was performed in a 50 µL reaction volume, containing 25 µL TaqMan 
Universal Master Mix; 0.9 µM IS900 Primer; 0.9 µM internal control 
primer; 0.1 µM IS900 FAM labeled probe; 0.1 µM internal control VIC 
labeled probe; 0.25 ng internal control plasmid and 10 µL of sample 
or control. The real-time PCR reaction conditions were as follows: 1 
cycle of 95°C for 10 minutes; and 45 cycles of 95°C for 15 seconds, 60°C 
for 1 minute. Cycle threshold values below 41 are considered positive 
for the presence of MAP. Sensitivity and specificity are 40% and 94%, 
respectively, when compared to environmental fecal analysis for MAP 
infection in dairy herds [34,35].
Testing for mycoplasma in bulk tank milk samples
Milk was cultured for mycoplasma on modified Hayflick medium, 
37 °C incubation in a 5% CO2 incubator. Plates were read at 3, 7 and 10 
d post- inoculation before being declared negative if no mycoplasma 
colonies were detected by that time, as described previously [33].
Testing for BVD in bulk tank milk samples
Milk samples were screened for BVD virus using a VetMAX™-Gold 
BVDV Detection Kit (Applied Biosystems, Carlsbad, CA, USA) real-
time reverse transcription PCR kit as per manufacturer’s instructions as 
reported previously [36]. Before detection samples were extracted using 
the MagMAX™ Total Nucleic Acid Isolation Kit (Applied Biosystems, 
Carlsbad, CA, USA). This kit employs mechanical disruption of samples 
with zirconia beads in a guanidinium thiocyanate-based solution that 
rapidly releases nucleic acid (NA) while simultaneously inactivating 
nucleases in the sample matrix [37,38]. Samples are then diluted with 
isopropanol, and paramagnetic beads with an NA binding surface are 
added to the sample. The beads/NA are immobilized on magnets and 
washed to remove proteins and other contaminants. A second wash 
solution is used to remove residual binding solution, and finally NA 
is eluted in a small volume of low-salt buffer. For amplification and 
detection of BVD 17 uL RT-PCR master mix were dispensed into each 
well of a PCR plate followed by 8 uL negative control (nuclease-free 
water), positive control, extraction control (mock-purified PBS), or test 
sample (milk) for a total volume in each well of 25 uL. The wells were 
then sealed with flat caps.
Amplification was performed using a Bio-Rad IQ5 Multicolor Real-
Time PCR Detection System. Two fluorescent dyes were used for RT-
PCR with different targets; FAM for BVD RNA, and Cal Fluor Orange 
560 dye for the Xeno RNA control (included in each sample as an 
internal control to ensure proper isolation).
Case definitions and statistical methods
The definition of “true positive” for JD, mycoplasma or BVD in a 
herd was the finding of at least 1 positive test result for that disease. 
Therefore by definition specificity (avoidance of false positives) was 
100%; no positive results were defined as “false positive”. Specificity 
for JD, mycoplasma, and BVD milk testing was previously reported as 
nearly 100%; false positive results are uncommon [33-35,39].
Test sensitivity (proportion of samples from true positive herds that 
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tested positive; avoidance of false negatives) was calculated for detection 
of each of the 3 diseases, analyzed separately. Sensitivity was defined 
as the total number of positive test results for a given disease divided 
by the total number of tests (ELISA and real-time PCR defined as one 
combined test for JD; there were single tests performed on each sample 
for mycoplasma and BVD) performed on all bulk milk samples from 
the herds detected at least once as positive for that disease. For example, 
if there were 284 JD-positive bulk tank samples among a total of 528 
bulk tank samples from all farms that tested positive for JD, sensitivity 
= 284/528 = 54% for a single bulk tank sample test to detect JD.
Using sequential probability, the probability that any particular 
herd for which all tests were negative was a “true negative” for each 
disease, analyzed separately, was calculated. First, the probability of 
false-negative status was calculated as (1- sensitivity)n where n = number 
of bulk tank milk tests performed. For example, if sensitivity was 54%, 
and one bulk tank was sampled and tested 5 times for JD with all tests 
negative, the probability of false-negative status for the disease would 
be (1-0.54)5 = (0.46)5 = 0.02. Then the probability of true-negative for 
JD status would be calculated as (1-0.02) = 98%. Farms with >5 total 
bulk tank tests because they had more than one tank would have a 
higher probability of being true-negative.
Confidentiality of results
Farms were coded by number for anonymity by the 2 milk buyers; 
the investigators did not know the dairy producers’ identities. Owners 
of herds positive for any of the 3 diseases were contacted through the 
milk buyer field personnel using their number code; if they confirmed 
that they would allow their identification to be revealed, their identities 
were revealed to the investigators. This allowed tracking of individual 
herds over time, and contact for a follow up program including farm 
visits.
Results
Sample collection
Signed forms authorizing milk sample collection and testing were 
returned by 151/209 (72%) of the dairy producers in the study area of 
Utah and adjacent areas of the Intermountain West. Bulk tank milk 
samples (n = 1,822, 911 pairs) were collected from all 179 bulk tanks on 
the 151 participating dairy farms, sampled 3-4 days apart. The number 
of bulk tank milk samples collected per farm ranged from 4 (8 farms) 
to 38 (1 farm). All samples were frozen as described earlier, and arrived 
frozen at the testing laboratories.
Herds testing positive for at least one disease
There were 68 herds (45%) that tested positive for one or more of the 
3 diseases; 61 herds were positive for one of the diseases, 6 herds were 
positive for 2 of the diseases, and one herd was positive for all 3 diseases. 
The remaining 83 herds (55%) tested negative for JD, mycoplasma and 
BVD. All combinations of proportion of bulk tank milk samples testing 
positive for each disease, number of samples collected, and the number 
of farms with each combination of results are shown in Table 1. For 
example, 5 farms had 10/10 samples positive for JD, and 3 farms had 1/5 
samples positive for BVD (Table 1).
Herd-level prevalence of JD
Johne’s disease was detected in bulk tank milk by at least one test 
from 58/151 dairy herds (38%) in Utah and adjacent study areas (Table 
1). Some of these herds were also positive for mycoplasma or BVD, and 
one had all 3 diseases (more details regarding multiple infections will 
follow). The proportion of bulk tank samples testing JD-positive among 
the positive herds ranged from 100% (19 herds) to 5% (one herd). The 
median proportion of bulk tanks testing JD-positive among all positive 
herds was 3/5 (60%) (Table 1). Variability in shedding of MAP was 
evident in the case of the farm with the largest number of bulk tank 
samples collected (38 samples). That farm had 3 bulk tanks, all with 
milk picked up twice every day, sometimes 3 times within 24 h. All 6 
Disease
JD Mycoplasma BVD 
Pos./No. tank 
samples (n) *
Pos./No. tank 
samples (n) * Pos./No. tank samples (n)
 *
15/15 (1) 4/10 (1) 9/9 (1)
12/12 (1) 6/18 (1) 5/5 (2)
11/11 (1) 3/11 (1) 7/9 (1)
10/10 (5) 4/22 (1) 4/11 (1)
9/9 (1) 1/4 (1)
5/5 (9) 1/5 (3)
4/4 (1) 1/6 (3)
5/6 (2) 3/25 (1)
10/12 (1) 1/16 (1)
8/10 (1)
4/5 (2)
7/10 (1)
16/25 (1)
3/5 (2)
5/9 (1)
12/22 (1)
15/30 (1)
2/4 (1)
2/5 (4)
2/8 (1)
2/6 (2)
2/10 (2)
1/5 (7)
1/6 (1)
6/38 (1)
1/9 (1)
1/10 (3)
1/12 (1)
1/17 (1)
1/21 (1)
58 (38%) 4 (3%) 14 (9%) Total positive herds†
93 (62%) 147 (97%) 137 (91%) Total negative herds‡
* Number of samples that tested positive of the total number of tank samples 
collected from herds detected with that disease. (n) = the number of herds with that 
combination of test results
† Total number and (percent) of herds positive for each disease
‡ Total number and (percent) of herds test-negative for each disease
Table 1: Bulk tank test results for presence of Johne’s disease (JD), Mycoplasma 
spp. and Bovine Viral Diarrhea (BVD) in 151 dairy herds with 179 bulk tanks in Utah 
and parts of surrounding states.  All combinations of proportion of positive samples 
and number of bulk tank samples collected are shown for each disease.
Citation: Wilson DJ, Rood KA, Bunnell J, Whitehouse C, Byrem TM (2014) Johne’s disease, Mycoplasma and BVD in Utah-Bulk Tank Milk Testing 
and Comparison to Previous Regional Prevalence and Individual Herd Results over Time. J Veterinar Sci Technol 5: 182. doi:10.4172/2157-
7579.1000182
Page 4 of 7
Volume 5 • Issue 3 • 1000182J Veterinar Sci TechnoloISSN: 2157-7579 JVST, an open access journal 
JD-positive tank results – from 2 of the 3 tanks only – were JD-negative 
when collected approximately 12 hours earlier or later on the same day.
Herd-level prevalence of mycoplasma
Mycoplasma was detected in bulk tank milk by at least one test 
from 4/151 herds (3%) (Table 1). Two of the 4 herds were JD-positive 
also, and one had all 3 diseases including BVD. The proportion of their 
bulk tanks testing mycoplasma-positive were similar for all 4 herds: 
6/18 (33%), 4/22 (18%), 4/10 (40%), 3/11 (27%). All of the farms that 
tested positive for mycoplasma had more than one bulk tank, and most 
or all tanks on a given farm were positive on some sample dates, while 
all tanks on the same farm were negative on other sample dates.
Herd-level prevalence of BVD
At least one test of bulk tank milk detected BVD from 14/151 herds 
(9%). Four of the 14 herds were JD-positive also, and another herd was 
positive for mycoplasma and JD as well (Table 1). The proportion of 
their bulk tanks testing BVD-positive ranged from 100% (3 herds) to 
6% (one herd). The median proportion of their bulk tanks testing BVD-
positive was 1/5 (Table 1).
Johne’s disease prevalence changes over time
Using the same tests as in the current study, the same dairy region 
was surveyed previously for JD in 2009, with 67/170 (39%) of dairy 
herds detected with JD [32]. However, the previous study collected 
2 samples from every bulk tank while the current study collected 5 
samples per tank. Of the 67 herds positive for JD in 2009, 28 (42%) 
remained positive in 2013, 14 (21%) became test-negative, 4 (6%) did 
not participate, and 21 (31%) exited the industry or changed to a non-
participating buyer by 2013.
Of the 103 herds that were JD test-negative in 2009, 65 were re-
tested 4 years later, and 13 (20%) became newly test-positive. There 
were 44 herds that did not participate in the previous surveillance 
project for JD (43 of the herds existed in 2009, one herd was assembled 
after 2009) and were therefore tested for JD for the first time in 2013; 
17 (39%) tested JD-positive – the herd assembled after 2009, and 16 
that did not participate in the earlier surveillance project. Therefore the 
apparent herd-level new infection rate for JD was 20% over a 4 year 
period for herds tested negative previously and the JD prevalence was 
39% for herds not tested before. The overall herd-level prevalence of JD 
in Utah and surrounding areas remained essentially unchanged over 4 
years, 39% to 38%.
Mycoplasma prevalence changes over time
The same dairy region was previously surveyed for mycoplasma in 
2007, using the same test methods and sampling scheme as the present 
study, with 16/222 (7%) of dairy herds detected with mycoplasma [33]. 
Of the 16 herds positive for mycoplasma in 2007, one (6%) remained 
positive in 2013 (the herd with all 3 diseases), 8 (50%) became test-
negative (3 of those were already known to be test-negative by 2008 
by the authors working closely with the owners, and they remained 
negative in 2013), 2 (13%) did not participate, and 5 (31%) exited the 
industry or changed to a non-participating buyer by 2013.
Of the 206 herds that were mycoplasma test-negative in 2007, 116 
were re-tested 6 years later, and one (1%) became newly test-positive. 
There were 26 herds that did not participate in the previous surveillance 
project for mycoplasma (25 of the herds existed in 2007, one herd was 
assembled after 2007) and were therefore tested for mycoplasma for 
the first time in 2013; 2 (8%) tested mycoplasma-positive – the herd 
assembled after 2007, and one that did not participate in the earlier 
surveillance project. Therefore the apparent herd-level new infection 
rate for mycoplasma mastitis was 1% over a 6 year period for herds tested 
negative previously and the mycoplasma prevalence was 8% for herds 
not tested before. The overall herd-level prevalence of mycoplasma in 
Utah and surrounding areas decreased from 7% to 3% over 6 years.
Bulk tank test sensitivity
Test sensitivity for JD detection was calculated by dividing the 
total number of JD-positive bulk tank results (whether by either the 
ELISA, real-time PCR, or both tests) by the total number of bulk tank 
milk samples tested from the JD-positive farms. There were 284 JD-
positive bulk tank samples among the 528 bulk tank samples from the 
58 positive farms; therefore 284/528 = 54% sensitivity of a single bulk 
tank sample test for detection of JD.
Calculated in the same way, sensitivity of testing (proportion of 
samples from true positive farms that tested positive) was: 17/61 = 28% 
for mycoplasma, 41/117 = 35% for BVD.
Estimates of true-negative status for 100% test-negative herds
Because the bulk tank sample test sensitivity for detection of JD 
was 54%, the probability of false-negative results on a single negative 
tank test was (1 – 0.54) = 0.46. The probability of true-negative JD 
status depending on the number of bulk tank milk samples tested from 
any given farm was calculated as described earlier. For example, for 
farms with one bulk tank, 5 samples collected 3-4 days apart, with all 5 
samples testing negative (by both ELISA and real-time PCR) for JD, the 
true-negative probability was [1 - (0.46)5] = (1-0.02) = 98%. For farms 
with more than one bulk tank, with all results negative for JD, the true-
negative probability was greater, [1 - (0.46)n] where n = the number of 
samples that tested negative for JD.
For mycoplasma detection, with test sensitivity of 28%, the 
probability of false-negative results on a single negative tank test was (1 
– 0.28) = 0.72. For farms with one bulk tank, with all 5 samples testing 
negative for mycoplasma, the true-negative probability was [1 - (0.72)5] 
= (1-0.19) = 81%.
For BVD detection, with test sensitivity of 35%, the probability of 
false-negative results on a single negative tank test was (1 – 0.35) = 0.65. 
For farms with one bulk tank, with all 5 samples testing negative for 
BVD, the true-negative probability was [1 - (0.65)5] = (1-0.12) = 88%. 
As explained for JD above, for mycoplasma and BVD it was also true 
that for farms with more than one bulk tank, with all results negative for 
either disease, the true-negative probability was greater.
Discussion
Approximately 40% of dairy herds in Utah and parts of surrounding 
states tested positive for JD, the same as 4 years earlier. These results 
are similar to other recent estimates of herd-level prevalence of JD 
in the US, supporting the speculation that the proportion of herds 
infected has increased over the last 15 to 20 years [13,14]. However, 
it is encouraging that JD prevalence apparently did not increase from 
2009 to 2013, suggesting that the herd-level new infection rate may 
be slowing. The predominant characteristic of prevalence estimates 
for JD in North America is that data is lacking; there is little testing 
for paratuberculosis carried out in dairy herds [40]. The lack of data 
regarding JD prevalence also exists in Europe. Recently a review of the 
European literature concluded that “prevalences of MAP would have to 
be guesstimates based on available data” and “there is a continuing need 
for well-designed studies of the prevalence of MAP infections” [41].
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Compared to 4 years earlier, two-thirds of previously JD-positive 
herds that were retested remained positive. This agrees with previous 
experience and reports that JD is difficult to eliminate from dairy 
herds. The most surprising thing about these results was that one-
third became test-negative, a higher proportion than expected. Despite 
the mathematical calculations and the accepted use of sequential 
probability in repeat testing, the authors suspect that most of those 
herds probably still have some cows infected with JD, possibly in small 
numbers of cows. All of the herds with which the authors worked 
closely following the previous surveillance project reduced within-
herd prevalence of JD, but none achieved complete elimination based 
on individual cow testing. Of the herds tested negative previously, 20% 
became test-positive for JD 4 years later, but JD prevalence was 39% for 
herds that had not been tested before, similar to the prevalence found in 
herds of unknown status in the first surveillance project.
Herds testing positive for mycoplasma in Utah decreased from 
7% in 2007 to 3% in the present study. This was in association with 
a farm-specific outreach and follow up program, and also large group 
meeting and dairy press presentations in Utah and the Intermountain 
West regarding mycoplasma testing and culling. Proportion of dairy 
herds testing positive in milk for mycoplasma had been observed to be 
increasing for many years [18,20,42], but may be decreasing recently 
at least in some regions, as producers and veterinarians are not only 
more familiar with the disease, but more are utilizing screening and 
monitoring programs for the disease.
A potential limitation of this study is that Mycoplasma spp. were 
not differentiated. This is the way that most testing for mycoplasma is 
done in the dairy industry because speciation is expensive and has little 
demonstrated benefit. In previous studies, most mycoplasma detected 
in milk of dairy cows has been M. bovis, or other species pathogenic to 
dairy cattle [18,42].
Test sensitivity of a single bulk tank milk culture for mycoplasma 
was lower than previously reported, 28% compared with earlier 
sensitivities of approximately 50% [33,42]. All mycoplasma-positive 
herds were positive in most tanks only on certain sample dates, and 
completely negative on other sample dates, reinforcing the concept that 
mycoplasma is shed intermittently into milk and repeated sampling 
increases the probability of detecting truly infected herds [33].
Compared to 6 years earlier, the vast majority of previously 
mycoplasma-positive herds that were retested, nearly 90%, became 
test-negative (the only herd remaining positive for mycoplasma was the 
only herd that also had JD and BVD). The remaining positive herd’s 
management has told the authors for years that they have no control 
program for the 3 diseases, including any testing, culling or herd 
replacement screening. This high proportion of mycoplasma-infected 
herds becoming test-negative agrees with the experience of one of the 
authors (DW). Mycoplasma is an important disease, and leaving it 
in a herd long-term has always been part of the history of the worst 
clinical outbreaks causing marked death, culling and financial losses. 
Therefore “living with it” is not a recommended strategy; testing and 
culling positive cows is recommended, especially due to the contagious 
nature of mycoplasma infections. Three of the 8 previously positive 
farms that tested mycoplasma-negative in the current study had worked 
closely with the authors and became test-negative within one year after 
the previous study, and two others were actively testing for and culling 
positive cows then. Nevertheless, it has been observed that mycoplasma-
positive herds often become completely test-negative in the milk of 
the adult herd within 18 - 24 months following initial detection even 
without intense elimination efforts. Of > 100 herds tested negative 
previously, only one became test-positive for mycoplasma 6 years later, 
but mycoplasma prevalence was 8% for herds that had not been tested 
before, similar to the prevalence found in herds of unknown status in 
the first surveillance project.
The overall detection percentage of BVD-positive farms, 9%, was 
similar to that reported following a national survey in 2007, which 
found 8% of western dairy farms BVD-positive [43]. This was lower 
than an earlier report of 12% herd-level BVD prevalence on New York 
dairy farms [44]. One limitation of using bulk tank samples to detect 
BVD is the possibility that all PI animals in a herd may not be lactating 
when samples are collected.
Five farms had multiple bulk tank samples positive for BVD. We 
are confident that farms with multiple BVD-positive test results were 
truly infected with BVD (likely the result of one or more PI animals 
present in the herd) because of previously reported high sensitivity and 
specificity using RT-PCR on bulk tank samples to detect PI animals 
[44,45].
Two known reasons may explain why some farms only had a single 
sample detected as BVD-positive. Persistently infected animals may 
have either been removed from or added to the lactating herd during 
the sampling period. Also, Drew et al. [45] suggested that as the total 
number of cows’ milk in a tank increased, the likelihood of BVD 
detection decreased because of dilution. Renshaw et al. [44] suggested 
that 1:600 ratio of PI’s to total number of milked animals was the 
upper limit of BVD detection because of dilution. The number of cows 
milked into each bulk tank was not determined in this project. Many 
dairy farms had multiple tanks and the number of cows milked into a 
particular tank was not consistent depending on pickup date and time.
Testing of dairy herds for Johne’s disease, mycoplasma and 
BVD has been increasingly adopted in recent years, but such testing 
is still underutilized, especially in screening dispersing herds for 
possible purchase as replacements in the dairy industry. Given the 
test sensitivities of a single bulk tank milk culture for detection of 
the 3 diseases reported here, a minimum of 4 but preferably at least 
5 bulk tank samples from each tank on a farm should be tested for 
screening its herd. If all 5 samples are test-negative, there is a high 
statistical probability that the herd is truly negative for Johne’s disease, 
mycoplasma and BVD. Nevertheless, if the proportion of cows infected 
is low, and/or most infected cows happen to be in a hospital string such 
that their milk is discarded from shipment, truly positive herds may still 
not be detected by bulk tank cultures. Any positive test result indicates 
high likelihood that the herd is infected; these are highly specific tests. 
However, if a dairy producer is reluctant to progress to individual 
cow testing for any of the diseases after one positive bulk tank result, 
additional bulk tank tests could be performed until there is another 
positive result. An ongoing repeated testing strategy on bulk tank 
milk such as collecting monthly samples is a convenient and practical 
method to screen for the presence of Johne’s disease, mycoplasma and 
BVD in dairy herds.
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